Add like
Add dislike
Add to saved papers

Alcohol intake and risk of renal cell carcinoma: a meta-analysis of published case-control studies.

INTRODUCTION: While some studies have indicated that alcohol intake is associated with a decreased risk of renal cell carcinoma, others have not. We conducted a meta-analysis of case-control studies to provide a quantitative assessment of the association between alcohol intake and the risk of renal cell carcinoma.

MATERIAL AND METHODS: We identified studies by a literature search of PubMed and review of references of relevant articles. Both the fixed and random-effects models were used to obtain the summary risk estimates associated with the highest versus the lowest consumption categories depending on the heterogeneity of effects among studies. Dose-response meta-analysis was performed for studies reporting categorical risk estimates for a series of exposure levels.

RESULTS: Fifteen studies were included in this meta-analysis. An inverse association between alcohol consumption and renal cell carcinoma was observed in both the overall alcohol intake group (OR 0.67, 95% CI 0.62-0.73) and subgroups stratified by sex, study design, geographical region, specific beverages and alcohol assessment. The dose-response meta-analysis showed that an increase in alcohol consumption of 12 g of ethanol per day was associated with a 5% statistically significant decreased risk of renal cell cancer.

CONCLUSIONS: High alcohol consumption exhibits a preventive effect for renal cell carcinoma in a dose-response manner. Further efforts should be made to clarify the underlying biological mechanisms.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app